Aug 2026· Drug Discovery Today· Vol 31, pp.
104784
· 0 citations· 59 references
Medicine
TL;DR
The present review provides an overview of the biochemical and pharmacological mechanisms of chromatin-modifying drugs, and some downstream effects of the aforementioned chromatin-modifying drugs.
Abstract
Epigenomic dysregulation is associated with several noncommunicable diseases (NCDs). Chromatin-modifying drugs have the ability to re-establish normal epigenetic regulation, thereby fine-tuning the epigenome. The biochemical and pharmacological mechanisms of these drugs, which target histone lysine and arginine methyltransferases, DNA methyltransferases, histone deacetylases and histone acetyltransferases, histone demethylases and bromodomain and extra-terminal motifs, serve as ideal tools for understanding the modes of action of these epigenetic regulators and the resulting biological events within chromatin. The present review provides an overview of these biochemical mechanisms and some downstream effects of the aforementioned chromatin-modifying drugs.
The pathogenesis and progression of cardiometabolic diseases (CMD) are intricately linked to epigenetic regulation mediated by chromatin remodeling. Modifications to histones, such as post-translational acetylation and methylation, along with DNA methylation, alter chromatin structure and accessibility, resulting in tr...
Mirjana Macvanin, Aleksandra Klisić· Journal of Cardiovascular Tr...· 0 citations
Post-translational modifications (PTMs) of histone H3 at lysine 9 (H3K9) contribute to chromatin homeostasis and transcriptional regulation and have been implicated in cancer progression. However, how distinct H3K9 modification states differ in function, compete for the same lysine residue, and dynamically respond to c...
This review comprehensively summarizes the multifaceted roles of major histone modifications, including acetylation, methylation, ubiquitination, phosphorylation, and emerging metabolism-linked acylations, in governing critical DNA-templated processes such as replication, transcription, and the DNA damage response.
Ling-Li Wang, Shi-Ying Li, Xiao-Yan Hu et al.· Precision Clinical Medicine· 1 citation
Abnormal epigenetic modifications are involved in central nervous system (CNS) diseases. Histones play a crucial role in chromatin structure and function, whose post-translational modifications significantly impact gene expression and chromatin dynamics. Histone acetylation, governed by the balance between histone acet...
Xiao-Ming Xin, Ling-Juan Wu, Mei-Chen Liu et al.· Frontiers in Molecular Neuro...· 0 citations
Although preclinical studies have validated ASF1A as a promising prognostic biomarker and therapeutic target, relevant clinical trials supporting its clinical application remain absent.
Jun Yin, Xiao-Jian Zhuo, Li-Hui Wen et al.· Experimental and Therapeutic...· 0 citations
It is suggested that the interaction between epigenetic and epitranscriptomic mechanisms is a key factor in determining risk and resilience for neuropsychiatric disorders, and offers new directions for future research and therapy development.
Y. Dwivedi, B. Roy· Brain : a journal of neurolo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
